Oshi, M.; Takahashi, H.; Tokumaru, Y.; Yan, L.; Rashid, O.M.; Matsuyama, R.; Endo, I.; Takabe, K.
G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer. Int. J. Mol. Sci. 2020, 21, 2921.
https://doi.org/10.3390/ijms21082921
AMA Style
Oshi M, Takahashi H, Tokumaru Y, Yan L, Rashid OM, Matsuyama R, Endo I, Takabe K.
G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer. International Journal of Molecular Sciences. 2020; 21(8):2921.
https://doi.org/10.3390/ijms21082921
Chicago/Turabian Style
Oshi, Masanori, Hideo Takahashi, Yoshihisa Tokumaru, Li Yan, Omar M. Rashid, Ryusei Matsuyama, Itaru Endo, and Kazuaki Takabe.
2020. "G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer" International Journal of Molecular Sciences 21, no. 8: 2921.
https://doi.org/10.3390/ijms21082921
APA Style
Oshi, M., Takahashi, H., Tokumaru, Y., Yan, L., Rashid, O. M., Matsuyama, R., Endo, I., & Takabe, K.
(2020). G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer. International Journal of Molecular Sciences, 21(8), 2921.
https://doi.org/10.3390/ijms21082921